Results:28 cases were found to have hepatic perfusion disorders(21.1%, 28/133). The common cause was HCC(22.5%, 20/89), especially HCC with portal vein tumor thrombus(46.2%, 12/26).

结果：有28例发现肝脏灌注异常影像表现（21.1%，28/133），以原发性肝细胞癌为多见（22.5%，20/89），尤其是合并门静脉癌栓的肝癌病例（46.2%，12/26）。

youdao

Conclusions Antiviral therapy improves the prognosis of HBV-related HCC. It should be considered after hepatectomy for HBV-related HCC, especially in early-stage tumors.

抗病毒治疗能改善乙肝相关肝癌的预后。对于乙肝相关肝癌手术治疗后的患者建议抗病毒治疗，尤其对于肿瘤早期的患者。

youdao

Regular screening for HCC is necessary for NASH patients, especially the elderly men with multiple metabolic disorders.

有必要对合并多元代谢紊乱的NASH患者，尤其是男性和年老患者进行定期HCC筛检。

youdao

Regular screening for HCC is necessary for NASH patients, especially the elderly men with multiple metabolic disorders.

有必要对合并多元代谢紊乱的NASH患者，尤其是男性和年老患者进行定期HCC筛检。

youdao